New treatment option for Heart Failure
Official title Eccentric Resistance Training Among Individuals With Chronic Heart Failure
ClinicalTrials.gov ID: NCT06032780
What this study is testing
- What it's testing
- To determine the effects of eccentric resistive training on ventricle functions and aerobic capacity as compared to a resistance and aerobic training among Heart failure (HF)
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosis of Chronic HF and currently stable with optimal medical therapy
- Chronic Heart failure with ejection fraction \> 30 %
- Patient able to safely perform lower limb exercise will be check by six- minute walk test (6 MWT)
You likely can't join if
- Those Heart failure patient whose are in acute phase or planed for any immediate medical intervention
- Already participating in cardiac rehabilitation
- New York Heart Association (NYHA) Classification of HF class IV HF symptoms
- Co-existent other disease such as asthma/ COPD/interstitial lung disease.
- Symptomatic Second degree or third degree heart block.
- ECG with uncontrolled ventricular arrhythmia
See the full eligibility criteria
- Diagnosis of Chronic HF and currently stable with optimal medical therapy
- Chronic Heart failure with ejection fraction \> 30 %
- Patient able to safely perform lower limb exercise will be check by six- minute walk test (6 MWT)
- Those Heart failure patient whose are in acute phase or planed for any immediate medical intervention
- Already participating in cardiac rehabilitation
- New York Heart Association (NYHA) Classification of HF class IV HF symptoms
- Co-existent other disease such as asthma/ COPD/interstitial lung disease.
- Symptomatic Second degree or third degree heart block.
- ECG with uncontrolled ventricular arrhythmia
- Limited Exercise ability due to neurologic or orthopedic impairments of the legs (will cross-check with 6 MWT)
The study team makes the final eligibility decision.
Where it's taking place
- Rawalpindi, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rawalpindi, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.